EA
LRMR icon

Emerald Acquisition’s Larimar Therapeutics LRMR Stock Holding History

Emerald Acquisition’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$208K Buy
+5,243
New +$238K ﹤0.01% 2682

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Acquisition's LRMR Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Larimar Therapeutics (LRMR) in Q3 2016: 5,243 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings.

77 funds tracked by Wall St. Rank hold LRMR as of Q3 2016.

  • Emerald Acquisition held 5,243 shares of Larimar Therapeutics worth $208K as of Q3 2016.
  • Larimar Therapeutics was a new Emerald Acquisition position in Q3 2016.
  • Larimar Therapeutics made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2682 holding.
  • 77 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.